Inoviq Ltd (AU:IIQ) has released an update.
INOVIQ Ltd, a pioneering biotech firm, will be spotlighting its advancements in cancer diagnostics and therapeutics during an investor presentation by CEO Dr. Leearne Hinch, scheduled for April 12, 2024. The company is recognized for its innovative EXO-NET exosome isolation technology and is actively developing clinical-stage diagnostics for ovarian and breast cancers, in addition to exploring exosome therapeutics for solid tumors. Interested investors can register online to attend the presentation and learn more about INOVIQ’s cutting-edge medical technologies.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
